Literature DB >> 8597880

Involvement of substance P as a mediator in capsaicin-induced mouse ear oedema.

H Inoue1, N Nagata, Y Koshihara.   

Abstract

We examined the involvement of substance P (SP) in mouse ear oedema induced by topical application of capsaicin (250 micrograms/ear). Reapplication of capsaicin at 4 h, 24 h, and 48 h after initial treatment did not induce a second oedema response. Oedema induced after the second application was significantly (p < 0.01 or p < 0.001) suppressed for up to 30 days but was observed when capsaicin was applied 40 days after initial treatment. Topical pretreatment of ears with capsaicin at 4 h, 24 h and 48 h before i.v. injection of SP (5 micrograms/kg) did not cause a significant inhibition of plasma extravasation in ear skin. NK1 receptor antagonists such as RP 67580 (ED50:0.19 mg/kg, i.v.), spantide II (ED50:0.33 mg/kg, i.v.), and GR 82334 (ED50:0.26 mg/kg, i.v.), inhibited capsaicin-induced ear oedema, whereas SR 48968 (2.0 mg/kg, i.v.), a NK2 receptor antagonist, had no effect. Furthermore, RP 67580 (0.5 kg/mg, i.v.) inhibited the oedema response induced by reapplication of capsaicin at 50 days after initial treatment. These results indicate that tachyphylaxis of capsaicin-induced oedema is reversible and suggest that this response may be due mainly to a reduction of SP in sensory neurones but not to any loss of responsiveness of NK1 receptors. We also conclude that SP and NK1 receptors are involved predominantly in the development of capsaicin-induced mouse ear oedema.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8597880     DOI: 10.1007/bf01837912

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  31 in total

1.  A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor.

Authors:  X Emonds-Alt; P Vilain; P Goulaouic; V Proietto; D Van Broeck; C Advenier; E Naline; G Neliat; G Le Fur; J C Brelière
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

2.  Tachykinin receptor types: Classification and membrane signalling mechanisms.

Authors:  S Guard; S P Watson
Journal:  Neurochem Int       Date:  1991       Impact factor: 3.921

3.  NK1 receptors mediate tachykinin-induced plasma extravasation in the rat knee joint.

Authors:  Y Hirayama; R Yasumitsu; A Kawamura; T Fujii
Journal:  Agents Actions       Date:  1993-11

4.  Spantide II, a novel tachykinin antagonist, and galanin inhibit plasma extravasation induced by antidromic C-fiber stimulation in rat hindpaw.

Authors:  X J Xu; J X Hao; Z Wiesenfeld-Hallin; R Håkanson; K Folkers; T Hökfelt
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

Review 5.  Tachykinin receptors and tachykinin receptor antagonists.

Authors:  C A Maggi; R Patacchini; P Rovero; A Giachetti
Journal:  J Auton Pharmacol       Date:  1993-02

6.  NK2 receptors mediate plasma extravasation in guinea-pig lower airways.

Authors:  C Tousignant; C C Chan; D Guevremont; C Brideau; J J Hale; M MacCoss; I W Rodger
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

7.  Responses of single nerve fibres to capsaicin applied to the skin.

Authors:  P Kenins
Journal:  Neurosci Lett       Date:  1982-03-17       Impact factor: 3.046

8.  Development and inhibition of mouse ear oedema induced with capsaicin.

Authors:  M Gábor; Z Rázga
Journal:  Agents Actions       Date:  1992-05

9.  Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin.

Authors:  J C Foreman; C C Jordan; P Oehme; H Renner
Journal:  J Physiol       Date:  1983-02       Impact factor: 5.182

10.  Role of substance P in immediate-type skin reactions induced by staphylococcal enterotoxin B in unsensitized monkeys.

Authors:  G Alber; P H Scheuber; B Reck; B Sailer-Kramer; A Hartmann; D K Hammer
Journal:  J Allergy Clin Immunol       Date:  1989-12       Impact factor: 10.793

View more
  10 in total

Review 1.  An updated review on molecular mechanisms underlying the anticancer effects of capsaicin.

Authors:  Seok-Cheol Cho; Hyosung Lee; Bu Young Choi
Journal:  Food Sci Biotechnol       Date:  2017-02-28       Impact factor: 2.391

2.  Role of substance P in renal injury during DOCA-salt hypertension.

Authors:  Youping Wang; Donna H Wang
Journal:  Endocrinology       Date:  2012-09-28       Impact factor: 4.736

3.  Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs.

Authors:  Punit P Shah; Pinaki R Desai; Apurva R Patel; Mandip S Singh
Journal:  Biomaterials       Date:  2011-11-26       Impact factor: 12.479

4.  Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.

Authors:  Punit P Shah; Pinaki R Desai; Debra Channer; Mandip Singh
Journal:  J Control Release       Date:  2012-05-14       Impact factor: 9.776

5.  Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.

Authors:  Punit P Shah; Pinaki R Desai; Mandip Singh
Journal:  J Control Release       Date:  2011-11-21       Impact factor: 9.776

6.  Effect of the tachykinin receptor antagonists, SR 140333, FK 888, and SR 142801, on capsaicin-induced mouse ear oedema.

Authors:  H Inoue; N Nagata; Y Koshihara
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

7.  Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II.

Authors:  R Jayachandra Babu; Loice Kikwai; Lasha T Jaiani; Narayanasamy Kanikkannan; Cheryl A Armstrong; John C Ansel; Mandip Singh
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

Review 8.  Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation.

Authors:  Frances Corrigan; Kimberley A Mander; Anna V Leonard; Robert Vink
Journal:  J Neuroinflammation       Date:  2016-10-11       Impact factor: 8.322

9.  A new pharyngitis model using capsaicin in rats.

Authors:  M Yamabe; T Hosokawa; T Taoka; M Misawa
Journal:  Gen Pharmacol       Date:  1998-01

10.  Cecropia pachystachya: a species with expressive in vivo topical anti-inflammatory and in vitro antioxidant effects.

Authors:  Natália Ramos Pacheco; Nícolas de Castro Campos Pinto; Josiane Mello da Silva; Renata de Freitas Mendes; Juliana de Carvalho da Costa; Danielle Maria de Oliveira Aragão; Maria Christina Marques Nogueira Castañon; Elita Scio
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.